Coya Therapeutics Inc (COYA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,944 | -5,052 | -7,988 | -9,254 | -5,832 |
| Depreciation Amortization | 14 | 7 | 27 | 21 | 14 |
| Accounts receivable | 7,500 | 7,500 | -7,500 | N/A | N/A |
| Accounts payable and accrued liabilities | 716 | 477 | 299 | -178 | -574 |
| Other Working Capital | 4,389 | 6,730 | -4,644 | -699 | -1,635 |
| Other Operating Activity | -7,093 | -7,517 | 8,617 | 1,162 | 1,296 |
| Operating Cash Flow | $-2,418 | $2,146 | $-11,189 | $-8,948 | $-6,732 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -25 | -25 | -543 | -350 | -350 |
| Investing Cash Flow | $-25 | $-25 | $-543 | $-350 | $-350 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 11 | 11 | N/A | N/A | N/A |
| Common Stock Issued | 6,512 | 1,362 | 38,425 | 14,250 | 14,250 |
| Other Financing Activity | -132 | -132 | 0 | 0 | 0 |
| Financing Cash Flow | $6,391 | $1,242 | $38,425 | $14,250 | $14,250 |
| Beginning Cash Position | 32,627 | 32,627 | 5,934 | 5,934 | 5,934 |
| End Cash Position | 36,575 | 35,989 | 32,627 | 10,886 | 13,102 |
| Net Cash Flow | $3,948 | $3,363 | $26,693 | $4,953 | $7,169 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,418 | 2,146 | -11,189 | -8,948 | -6,732 |
| Capital Expenditure | -25 | -25 | -543 | -350 | -350 |
| Free Cash Flow | -2,443 | 2,121 | -11,732 | -9,298 | -7,082 |